vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and MSCI Inc. (MSCI). Click either name above to swap in a different company.
MSCI Inc. is the larger business by last-quarter revenue ($822.5M vs $493.8M, roughly 1.7× Pediatrix Medical Group, Inc.). MSCI Inc. runs the higher net margin — 34.6% vs 6.8%, a 27.8% gap on every dollar of revenue. On growth, MSCI Inc. posted the faster year-over-year revenue change (10.6% vs -1.7%). Over the past eight quarters, MSCI Inc.'s revenue compounded faster (10.0% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
MSCI Inc. is an American finance company headquartered in New York City. MSCI is a global provider of equity, fixed income, real estate indices, multi-asset portfolio analysis tools, ESG and climate finance products. It operates the MSCI World, MSCI Emerging Markets, and MSCI All Country World (ACWI) indices, among others.
MD vs MSCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $822.5M |
| Net Profit | $33.7M | $284.7M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 56.4% |
| Net Margin | 6.8% | 34.6% |
| Revenue YoY | -1.7% | 10.6% |
| Net Profit YoY | 10.5% | -6.8% |
| EPS (diluted) | $0.40 | $3.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $822.5M | ||
| Q3 25 | $492.9M | $793.4M | ||
| Q2 25 | $468.8M | $772.7M | ||
| Q1 25 | $458.4M | $745.8M | ||
| Q4 24 | $502.4M | $743.5M | ||
| Q3 24 | $511.2M | $724.7M | ||
| Q2 24 | $504.3M | $707.9M | ||
| Q1 24 | $495.1M | $680.0M |
| Q4 25 | $33.7M | $284.7M | ||
| Q3 25 | $71.7M | $325.4M | ||
| Q2 25 | $39.3M | $303.6M | ||
| Q1 25 | $20.7M | $288.6M | ||
| Q4 24 | $30.5M | $305.5M | ||
| Q3 24 | $19.4M | $280.9M | ||
| Q2 24 | $-153.0M | $266.8M | ||
| Q1 24 | $4.0M | $256.0M |
| Q4 25 | 9.9% | 56.4% | ||
| Q3 25 | 13.8% | 56.4% | ||
| Q2 25 | 12.8% | 55.0% | ||
| Q1 25 | 7.0% | 50.6% | ||
| Q4 24 | 7.8% | 54.5% | ||
| Q3 24 | 6.6% | 55.4% | ||
| Q2 24 | -31.3% | 54.0% | ||
| Q1 24 | 3.2% | 49.9% |
| Q4 25 | 6.8% | 34.6% | ||
| Q3 25 | 14.5% | 41.0% | ||
| Q2 25 | 8.4% | 39.3% | ||
| Q1 25 | 4.5% | 38.7% | ||
| Q4 24 | 6.1% | 41.1% | ||
| Q3 24 | 3.8% | 38.8% | ||
| Q2 24 | -30.3% | 37.7% | ||
| Q1 24 | 0.8% | 37.6% |
| Q4 25 | $0.40 | $3.81 | ||
| Q3 25 | $0.84 | $4.25 | ||
| Q2 25 | $0.46 | $3.92 | ||
| Q1 25 | $0.24 | $3.71 | ||
| Q4 24 | $0.37 | $3.89 | ||
| Q3 24 | $0.23 | $3.57 | ||
| Q2 24 | $-1.84 | $3.37 | ||
| Q1 24 | $0.05 | $3.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $515.3M |
| Total DebtLower is stronger | $570.5M | $6.2B |
| Stockholders' EquityBook value | $865.9M | $-2.7B |
| Total Assets | $2.2B | $5.7B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $515.3M | ||
| Q3 25 | $340.1M | $400.1M | ||
| Q2 25 | $224.7M | $347.3M | ||
| Q1 25 | $99.0M | $360.7M | ||
| Q4 24 | $229.9M | $409.4M | ||
| Q3 24 | $103.8M | $501.0M | ||
| Q2 24 | $19.4M | $451.4M | ||
| Q1 24 | $8.0M | $519.3M |
| Q4 25 | $570.5M | $6.2B | ||
| Q3 25 | $577.2M | $5.5B | ||
| Q2 25 | $583.9M | $4.5B | ||
| Q1 25 | $590.5M | $4.5B | ||
| Q4 24 | $597.1M | $4.5B | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | — | $4.5B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $865.9M | $-2.7B | ||
| Q3 25 | $890.7M | $-1.9B | ||
| Q2 25 | $833.8M | $-886.2M | ||
| Q1 25 | $789.2M | $-958.6M | ||
| Q4 24 | $764.9M | $-940.0M | ||
| Q3 24 | $732.5M | $-751.0M | ||
| Q2 24 | $706.5M | $-734.5M | ||
| Q1 24 | $856.2M | $-650.5M |
| Q4 25 | $2.2B | $5.7B | ||
| Q3 25 | $2.2B | $5.4B | ||
| Q2 25 | $2.1B | $5.4B | ||
| Q1 25 | $2.0B | $5.3B | ||
| Q4 24 | $2.2B | $5.4B | ||
| Q3 24 | $2.1B | $5.4B | ||
| Q2 24 | $2.0B | $5.5B | ||
| Q1 24 | $2.2B | $5.5B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $501.1M |
| Free Cash FlowOCF − Capex | — | $488.7M |
| FCF MarginFCF / Revenue | — | 59.4% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | 3.39× | 1.76× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.5B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $501.1M | ||
| Q3 25 | $137.3M | $449.4M | ||
| Q2 25 | $137.2M | $336.1M | ||
| Q1 25 | $-117.5M | $301.7M | ||
| Q4 24 | $133.0M | $430.6M | ||
| Q3 24 | $91.8M | $421.6M | ||
| Q2 24 | $107.0M | $349.2M | ||
| Q1 24 | $-125.2M | $300.1M |
| Q4 25 | — | $488.7M | ||
| Q3 25 | — | $445.5M | ||
| Q2 25 | — | $324.7M | ||
| Q1 25 | — | $290.2M | ||
| Q4 24 | — | $416.4M | ||
| Q3 24 | — | $415.0M | ||
| Q2 24 | — | $340.6M | ||
| Q1 24 | — | $295.9M |
| Q4 25 | — | 59.4% | ||
| Q3 25 | — | 56.2% | ||
| Q2 25 | — | 42.0% | ||
| Q1 25 | — | 38.9% | ||
| Q4 24 | — | 56.0% | ||
| Q3 24 | — | 57.3% | ||
| Q2 24 | — | 48.1% | ||
| Q1 24 | — | 43.5% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 3.39× | 1.76× | ||
| Q3 25 | 1.91× | 1.38× | ||
| Q2 25 | 3.49× | 1.11× | ||
| Q1 25 | -5.66× | 1.05× | ||
| Q4 24 | 4.36× | 1.41× | ||
| Q3 24 | 4.72× | 1.50× | ||
| Q2 24 | — | 1.31× | ||
| Q1 24 | -31.03× | 1.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
MSCI
| Recurring Subscriptions | $246.4M | 30% |
| Asset Based Fees | $211.7M | 26% |
| Analytics Segment | $182.3M | 22% |
| Sustainability And Climate Segment | $90.3M | 11% |
| Other | $70.9M | 9% |
| Non Recurring | $21.1M | 3% |
